Restoring Health
& Extending Life
At The Heart Of Innovation
A Global Player In Minimally Invasive Structural Heart Devices
Pushing the boundaries of medical innovation, P&F Products & Features is a global leader in minimally invasive structural heart devices. Our mission is clear—to transform the treatment of structural heart conditions and improve the lives of patients worldwide. With cutting-edge technology, unwavering dedication to research and development, and a patient-centered approach, we are shaping the future of heart care.
Medical Congresses & Events
From Our Founders
DR. HON. PROF. KATHARINA KISS
CHIEF EXECUTIVE OFFICER
As a practicing cardiologist for over 20 years, I’ve managed care for thousands of patients suffering from heart valve disease with limited treatment options. As the CEO of Products & Features, my team and I are laser-focused on developing structural heart technologies that are designed for procedural ease and enhance patients’ quality of life. The TricValve system is a revolutionary innovation born from this focus on patients and physicians.
DR. PROF. SIEGFRIED EINHELLIG
COO & PRESIDENT
Great engineering equals simple solutions to complex problems. This phrase has guided my journey as an engineer and innovator. I’ve successfully launched several med-tech companies to meet the needs of patients with cardiovascular disease. P&F is the leader in innovating unique valve leaflet technology, an achievement that has been acknowledged by the FDA by granting TricValve Breakthrough Device Status. TricValve is unique in the sense that our technology allows for short intervention times combined with long device durability, thus providing benefits for patients, cardiologists, and healthcare systems alike.
Established and Fully Integrated Global Value Chain
Headquartered in Vienna, Austria, P&F Products & Features GmbH is a medical technology company focused on the research, development, and manufacturing of innovative minimally invasive solutions in the field of cardiology. P&F Products & Features is fully integrated with our in-house production process, from raw material to finished product, including dry pericardium, via our Brazilian facility.
R&D
R&D
In-house research & development with full capabilities
PRODUCTION
PRODUCTION
Nitinol stents designed by P&F are laser cut in Germany and shipped to Brazil for tissue attachment and pre-mounting
ASSEMBLY
ASSEMBLY
Delivery systems are premounted, packaged and shipped to Germany
QUALITY TESTING
QUALITY TESTING
LOGISTICS
LOGISTICS
Distribution to around 50 countries where P&F TricValve is approved for use
Engineering Life-Long Solutions
P&F Products & Features is poised for growth with a global, end-to-end approach across the entire value chain. With operation facilities in Germany, Portugal, Spain, and Brazil, our research and development capabilities are the foundation of our approach to innovation. While developing new products and enhancing existing ones, we aim to leverage these capabilities to generate distinctive value and expand access to state-of-the-art technology for patients and healthcare providers worldwide.
News & Resources
Press Releases, Publications and News, Downloads, and the Latest Media from P&F Products & Features
P&F Hosts Transformative 2025 Sales Meeting in Brazil and LATAM
A Milestone in Innovation and Collaboration From March 24 to 26, 2025, P&F Products & Features proudly hosted the 2025 Sales Meeting for Brazil and LATAM in São José do Rio Preto.
P&F Products & Features GmbH wins esteemed Houska Prize for innovation and excellence
P&F Products & Features GmbH is proud to announce that it has been awarded the esteemed Houska Prize for outstanding innovation and excellence in the “Research and Development in Small and Medium-Sized
P&F Products and Features GmbH Appoints Dr. Roswitha Wolfram as Global Chief Medical Officer
Long-time healthcare executive to lead worldwide medical team P&F Products and Features GmbH (P&F), a leading global medical technology company focused on developing innovative minimally invasive cardiology solutions, today announced the appointment